Search KLH Site
Find Articles by Tags
Addiction (18) Adjuvant - Alum (1) Adjuvant - GPI-0100 (1) Adjuvant - IL-4 (9) Adjuvant GM-CSF (16) Adjuvant KLH (4) Adjuvant Oil / Surfactant (4) Adjuvant QS-21 (25) Age & Physical Activity (3) Allergen-specific immunotherapy (1) Allergy – Pollen (2) Alzheimer's Disease (3) Antibody Response (35) Antibody Response IgA (14) Antibody Response IgE (6) Antibody Response IgG (106) Antibody Response IgM (71) Antibody Response IgY (1) APEC (1) Assay - Bioassay (2) Assay - Carbohydrate Microarray (1) Assay - ELISA (55) Assay - ELISPOT (7) Assay - Immunoassay (8) Assay - InVitro (18) Assay - InVivo (1) Atopic Dermatitis (1) Autoimmune Disease (1) B-epitope (1) Bone Marrow Transplant (6) Cancer (6) Cancer - Bladder (16) Cancer - Brain & CNS (8) Cancer - Breast (15) Cancer - Cervical (1) Cancer - Colorectal (10) Cancer - Esophageal (1) Cancer - Female Reproductive (7) Cancer - Leukemia (2) Cancer - Lung (4) Cancer - Lymphoma (25) Cancer - Melanoma (37) Cancer - Mesothelioma (1) Cancer - Myeloma (15) Cancer - Other (2) Cancer - Ovarian (3) Cancer - Pancreas (1) Cancer - Pediatric (3) Cancer - Peritoneal (2) Cancer - Prostate (9) Cancer - Renal (13) Cancer - Sarcoma (2) Clostridium difficile (5) Crohn's Disease (2) Cross-Reactive Antigens (6) Delayed-type hypersensitivity response (1) Dendritic Cell (66) Developmental (10) Diabetes (2) Disease Resistence (1) DNP-Ficoll (2) DTH (67) Environmental (15) Escherichia coli (1) Fingolimod (Gilenya) (1) Healthy Volunteers (18) HealthyAntibody Response - IgA (1) Hepatitis (2) HIV (11) HPV (3) Husbandry (3) Hypertension (1) id-KLH (29) IL 1 (4) IL 12 (2) IL 15 (1) IL 2 (10) IL 5 (1) IL 6 (1) IL 7 (1) Immune Disease - Autoimmune (13) Immune Disease - Primary (2) Immune Disease – Secondary (1) Immune Response - Cellular (187) Immune Response - Humoral (259) Immune Response Humoral (2) Immunotoxicity (37) Infection (1) Infectious Disease (5) Inflammatory Disease (1) Intradermal KLH (1) Kidney (1) KLH-BEC2 (1) KLH-BP16 (1) KLH-BPO (1) KLH-Conjugate (69) KLH-EGFR (2) KLH-FITC (1) KLH-Ganglioside (16) KLH-Globo H (7) KLH-GM2 (1) KLH-hD1 (1) KLH-HGP-30 (1) KLH-IL (1) KLH-Kinoid (8) KLH-Lewis Y (3) KLH-MUC (8) KLH-Oxycodone (2) KLH-sTn (9) KLH-TF (5) KLH-TN (3) Model - Canine (6) Model - Guinea Pig (10) Model - Livestock (10) Model - Mouse (73) Model - Other (32) Model - Primate (12) Model - Rat (51) Multiple Sclerosis (1) Nasal (3) Natrural Antibody (1) Neonatal (2) NK Cells (1) NSAID (1) Oral KLH (9) Oxycodone (3) Parasitic Disease (6) Pediatric (1) Plant-made (2) PLNA (1) Population Density (3) Psoriasis (1) Review Article (2) Rheumatoid Arthritis (11) Rituximab (Rituxan) (4) Russian thistle (1) Sal k 1 (1) Stress (8) Systemic Lupus Erythematosus (SLE) (7) TACA (2) TDAR (127) Therapeutics - KLH Alone (15) Transplant (6) Ultra Violet radiation (1) Uveitis (1) VEGF (3) Veterinary (1)
Terms and Privacy

KLH in Publications

Publications of scientific research involving KLH. Abstracts or full text articles are available by link to outside sites. If you know of a KLH-related publication that is not yet on KLH Site™, let us know.

(in order by date)

Entries in Cancer - Breast (15)

Monday
Feb082016

Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: Clinical and immunological data of a phase I/II clinical trial

MORENA ANTONILLI, HASSAN RAHIMI, VALERIA VISCONTI, CHIARA NAPOLETANO, ILARY RUSCITOLARIA GRAZIA ZIZZARI, SALVATORE CAPONNETTO, GIACOMO BARCHIESI, ROBERTA IADAROLA, LUCA PIERELLI, AURELIA RUGHETTI, FILIPPO BELLATI, PIERLUIGI BENEDETTI PANICI, and MARIANNA NUTI2 

 

 

Tuesday
Feb122013

Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer

Yen-Lin Huang, Jung-Tung Hung, Sarah K. C. Cheung, Hsin-Yu Lee, Kuo-Ching Chu, Shiou-Ting Li, Yu-Chen Lin, Chien-Tai Ren, Ting-Jen R. Cheng, Tsui-Ling Hsu, Alice L. Yu, Chung-Yi Wu, and Chi-Huey Wong

Proc Natl Acad Sci U S A. 2013 February 12; 110(7): 2517–2522.

Friday
Nov302012

Vaccination into the Tumor Microenvironment Using Recombinant Vaccinia Expressing HER2/NEU Leads to Tumor Regression and the Generation of a Tumor-specific Systemic T Cell Response in a Mouse Model of HER2/NEU-overexpressing Mammary Carcinoma

Christiaan R. de Vries1, Claude E. Monken2, Edmund C. Lattime3.

1 Department of Microbiology and Molecular Genetics, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ;
2 The Cancer Institute of New Jersey, New Brunswick, NJ;
3 Department of Surgery, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ.

Abstracts for the 27th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC);  J Immunotherapy, Vol. 35, No. 9, November–December 2012

Thursday
Oct202011

Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase І /II trial

Soyoung Baek, Choung-Soo Kim, Sung-Bae Kim, Yong-man Kim, Seog-Woon Kwon, YongMan Kim, HyunSoo Kim, Hyunah Lee

J Transl Med. 2011 Oct 20;9(1):178

Saturday
May142011

Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer

Miles D, Roché H, Martin M, Perren TJ, Cameron DA, Glaspy J, Dodwell D, Parker J, Mayordomo J, Tres A, Murray JL, Ibrahim NK; Theratope® Study Group.

Oncologist. 2011;16(8):1092-100. Epub 2011 May 14

Tuesday
May152007

Immunization of high-risk breast cancer patients with clustered sTn-KLH conjugate plus the immunologic adjuvant QS-21.

Gilewski TA, Ragupathi G, Dickler M, Powell S, Bhuta S, Panageas K, Koganty RR, Chin-Eng J, Hudis C, Norton L, Houghton AN, Livingston PO.

Clin Cancer Res. 2007 May 15;13(10):2977-85.

Saturday
Feb012003

The role of cancer vaccines following autologous stem cell rescue in breast and ovarian cancer patients: experience with the STn-KLH vaccine (Theratope).

Holmberg LA, Oparin DV, Gooley T, Sandmaier BM.

Clin Breast Cancer. 2003 Feb;3 Suppl 4:S144-51.

Sunday
Dec012002

In vitro anticancer effects of a novel immunostimulant: keyhole limpet hemocyanin

Riggs DR, Jackson B, Vona-Davis L, McFadden D.

J Surg Res. 2002 Dec;108(2):279-84

Saturday
Sep012001

Theratope vaccine (STn-KLH).

Holmberg LA, Sandmaier BM.

Expert Opin Biol Ther. 2001 Sep;1(5):881-91.

Monday
May012000

Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21

Gilewski T, Adluri S, Ragupathi G, Zhang S, Yao TJ, Panageas K, Moynahan M, Houghton A, Norton L, Livingston PO

Clin Cancer Res. 2000 May;6(5):1693-701

Thursday
Apr011999

Specificity analysis of sera from breast cancer patients vaccinated with MUC1-KLH plus QS-21

Adluri S, Gilewski T, Zhang S, Ramnath V, Ragupathi G, Livingston P

Br J Cancer. 1999 Apr;79(11-12):1806-12

Friday
Jan011999

Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine.

Sandmaier BM, Oparin DV, Holmberg LA, Reddish MA, MacLean GD, Longenecker BM.

J Immunother. 1999 Jan;22(1):54-66.

Wednesday
Jun101998

Anti-MUC1 class I restricted CTLs in metastatic breast cancer patients immunized with a synthetic MUC1 peptide.

Reddish M, MacLean GD, Koganty RR, Kan-Mitchell J, Jones V, Mitchell MS, Longenecker BM.

Int J Cancer. 1998 Jun 10;76(6):817-23.

Saturday
Jun011996

Pre-immunotherapy serum CA27.29 (MUC-1) mucin level and CD69+ lymphocytes correlate with effects of Theratope sialyl-Tn-KLH cancer vaccine in active specific immunotherapy.

Reddish MA, MacLean GD, Poppema S, Berg A, Longenecker BM.

Cancer Immunol Immunother. 1996 Jun;42(5):303-9.

Monday
Jan011996

Antibodies against mucin-associated sialyl-Tn epitopes correlate with survival of metastatic adenocarcinoma patients undergoing active specific immunotherapy with synthetic STn vaccine.

MacLean GD, Reddish MA, Koganty RR, Longenecker BM.

J Immunother Emphasis Tumor Immunol. 1996 Jan;19(1):59-68.